NCT02599415View on ClinicalTrials.gov

Anti-psoriatic Effect of TL01 Light Therapy

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Psoriasis
Interventions
DEVICE

TL01 light treatment

Patients received treatment in TL01 cabinet three sessions weekly according to a standard escalating protocol based on minimal erythema dose. Standard dose ranges between 0.55 and 3.13J/cm2.

Trial Locations (1)

AB25 2zb

University of Aberdeen, Aberdeen

All Listed Sponsors
collaborator

NHS Grampian

OTHER_GOV

lead

University of Aberdeen

OTHER

NCT02599415 - Anti-psoriatic Effect of TL01 Light Therapy | Biotech Hunter | Biotech Hunter